促肝细胞生长素注射液治疗慢性乙肝病人高胆红素血症  

Hepatocyte Growth-promoting Factors Injection in the Treatment of Hyperbilirubinemia in Patients with Chronic Hepatitis B

作　　者：许善战[1] 蔡修熙[1] 

机构地区：[1]浙江省台州医院感染科,317000

出　　处：《医学理论与实践》2002年第9期1003-1004,共2页The Journal of Medical Theory and Practice

摘　　要：目的:研究促肝细胞生长素注射液(威佳)在治疗慢性乙型肝炎(CHB)高胆红素血症中的作用。方法:将129例CHB病人随机分为A、B、C3组,A组采用威佳和常规护肝治疗,B组采用注射用促肝细胞生长素和常规护肝治疗,C组采用常规护肝治疗。结果:治疗后A、B组有效率高于C组;A组TB、DB下降程度明显好于B组。结论:威佳治疗CHB高胆红素血症有较好的疗效。Objective: To investigate the effect of hepatocyte growth-promoting factors injection (Weijia) in the treatment of hyperbilirubinemia in patients with chronic hepatitis B (CHB) . Methods: 129 patients with CHB were randomly divided into group A, B and C. Patients in all groups received routine treatment. However, patients in group A received Weijia, patients in group B received injectable hepatocyte growth-promoting factors. Results: After treatment, the effective rate in group A, B were higher than that in group C (P<0.05). the TB, DB in group A were decreased more than these in group B (P<0.05). Conclusion: Hepatocyte growth-promoting factors injection is a effective drug for treatment of hyperbilirubinemia in patients with CHB.

关 键 词：慢性乙型肝炎 促肝细胞生长素 高胆红素血症 治疗 

分 类 号：R512.62[医药卫生—内科学] R589.2[医药卫生—临床医学]